Aug 10, 2016 by Brian FeroldiWhy AMAG Pharmaceuticals, Inc. Is Tanking TodayShares fall despite reporting a second quarter earnings beat.
Aug 10, 2016 by Brian FeroldiTransEnterix Inc Q2 Earnings Show Reasons for Optimism, but the Clock Is TickingTransEnterix's second-quarter loss was lower than expected, and the company reported its first ALF-X sale, but is it too little, too late?
Aug 10, 2016 by Brian FeroldiWhy Spectrum Pharmaceuticals, Inc. Is in the Red TodayShares plunge in the wake of the company reporting second-quarter earnings.
Aug 10, 2016 by Brian FeroldiRegeneron Pharmaceuticals Inc.'s Q2 Earnings -- It's Still All About Eylea, but Not for Too Much LongerThe biotech heavyweight's earnings rose yet again solely because of strong Eylea sales, but there's potential for new drugs to hit the market soon that could help to carry the growth torch.
Aug 9, 2016 by Brian FeroldiWhy Array BioPharma Inc. Is Plunging TodayFailure in a key clinical trial caused shares to tank.
Aug 9, 2016 by Brian FeroldiHorizon Global Corp.'s Margin Gains Cause Profits to SurgeNet income more than doubles in the second quarter, indicating the company's long-term growth strategy is starting to pay off.
Aug 9, 2016 by Brian FeroldiWhy Nevro Corp. Is Up Big TodayShares jumped in response to blowout quarterly results.
Aug 9, 2016 by Brian FeroldiWhy Castlight Health Inc Is Surging TodayShares pop in response to an upbeat second-quarter earnings report.
Aug 6, 2016 by Brian Feroldi, Sean Williams, Jason Hall, Neha Chamaria, Steve Symington, Timothy Green, and Todd Campbell7 Top Stocks to Buy in AugustThe market may be at frothy levels, but our team of contributors think that these punished stocks are undervalued buys.
Aug 4, 2016 by Brian FeroldiFormFactor, Inc. Bounces BackThe company reported profit and earnings growth well ahead of expectations and issued a bullish outlook.
Aug 3, 2016 by Brian FeroldiRPX Corporation's Profits Fall Yet AgainAcquisitions helped to fuel big gains on the top line, but the company failed to translate that growth into higher earnings.
Aug 3, 2016 by Brian FeroldiCullen/Frost Bankers' Q2 Energy Losses Slow: Is the Worst Over?Cullen/Frost Bankers results hint that the worst of damage from the energy downturn might finally be in the rearview mirror.
Jul 30, 2016 by Brian FeroldiThese 3 Dividend Stocks Are Ridiculously CheapThese three companies are cheap and offer big dividend yields, but are they worth buying?
Jul 29, 2016 by Brian FeroldiEllie Mae Posts Strong Growth, Raises GuidanceThe mortgage-processing software specialist posts impressive results and bumps its full-year guidance.
Jul 29, 2016 by Brian FeroldiWhy Seres Therapeutics Inc. Is Being Obliterated TodayShares plunged in reaction to important study results that missed the mark.
Jul 29, 2016 by Brian FeroldiBetter Buy: Regeneron Pharmaceuticals vs. PfizerBoth are top healthcare stocks with strong pipelines.
Jul 28, 2016 by Brian Feroldi3 Stocks That Could Lose You a Lot of MoneyThese three companies are selling on the cheap, but I'd still suggest that investors stay away.
Jul 28, 2016 by Brian FeroldiWhy Novocure Ltd Is Plunging TodayShares drop sharply in response to a disappointing second-quarter earnings report.
Jul 28, 2016 by Brian FeroldiWhy Infinera Is Being Obliterated TodayShares plunge in response to management's forecast of a steep drop in revenue.
Jul 28, 2016 by Brian FeroldiNetSuite Inc's Shares Soar on News of an Oracle BuyoutOracle has agreed to buy NetSuite for $9.3 billion.
